Search results
Results from the WOW.Com Content Network
The Sikorsky CH-53K King Stallion (Sikorsky S-95) [2] is a heavy transport helicopter designed and produced by Sikorsky Aircraft.The King Stallion is an evolution of the long running CH-53 series of helicopters which has been in continuous service since 1966, and features three up-rated 7,500 shp (5,590 kW) engines, new composite rotor blades, and a wider aircraft cabin than its predecessors.
The new T408 (GE38-1B) is slated to power the new Sikorsky CH-53K King Stallion three-engined helicopter for the US Marine Corps. It has a power rating of 7,500 shp. [ 10 ] The GE38 completed its first round of ground testing in May 2010. [ 11 ]
CH-53G of the German Army flying in the Alps, 2005 CH-53K King Stallion. The Sikorsky H-53 is a family of military helicopters built by Sikorsky Aircraft.H-53 is its United States military designation; the company has several designations for it including S-65, S-80, and S-95.
Apart from spare parts procurement, Lockheed's (LMT) Sikorsky is set to offer support for the repair and maintenance of the CH-53K aircraft configuration. Lockheed Wins $55M Deal to Procure CH-53K ...
Lockheed (LMT) is going to provide non-recurring engineering, supplies and support necessary for the low-rate initial production Lot 1 deployable configuration updates for the CH-53K aircraft.
Lockheed Martin's (LMT) Sikorsky unit is going to offer CH-53K aircraft and associated aircraft, programmatic as well as logistical support.
The CH-53 Sea Stallion (Sikorsky S-65) is a family of American heavy-lift transport helicopters designed and built by the American manufacturer Sikorsky Aircraft.The Sea Stallion was originally developed in response to a request from the United States Navy's Bureau of Naval Weapons made in March 1962 for a replacement for the Sikorsky CH-37 Mojave helicopters flown by the United States Marine ...
Lockheed (LMT) is ramping up production of CH-53K with more than 30 aircraft in various stages of development and is on track for deployment in 2023 or 2024.